Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
Related Questions
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you differentiate between ocular involvement due to active tuberculosis versus latent infection in a patient with uveitis and suspected tuberculosis?
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
How do you decide on when to start or continue anti-VEGF injections during pregnancy?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
How do you approach the management of bilateral non-infectious uveitis in the pediatric population?
How do you approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
